Scarica l'app Stockscreener
0.7751
0.65%
0.005
Dyadic International Inc De Borsa (DYAI) Ultime notizie
Llamada de resultados del T2 de 2026 de Dyadic International (DYAI): progreso comercial y riesgo de liquidez - TradingKey
Dyadic International Announces New Equity Financing Agreements - TipRanks
Dyadic International (DYAI) Ergebniskonferenz Q2 2026: Kommerzielle Fortschritte und Liquiditätsrisiko - TradingKey
Dyadic International Earnings Call: Promise Amid Cash Strain - TipRanks
Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement - GlobeNewswire
Dyadic International Warns of Going-Concern Risk as Dilution, Nasdaq Uncertainty and Noteholder Dependence Threaten Shareholder Value - TipRanks
Dyadic International Q2 Results: EPS Misses Estimate, Sales Down 0.6% YoY - scanx.trade
Cellulase Silage Additives Market Growth to 2035 Driven by Asia-Pacific Livestock ExpansionNews and Statistics - IndexBox
Segmentation, Major Trends, and Competitive Overview of the Specialty Enzymes Market - openPR.com
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement - GlobeNewswire
Dyadic Delivers Two Bundibugyo Ebola Antigens for Preclinical Evaluation - Stock Titan
Form 4 Dyadic International Inc For: 25 July By Investing.com - Investing.com South Africa
Francisco trust disposes of $124,957 in Dyadic International stock By Investing.com - Investing.com Canada
Dyadic Regains Nasdaq Compliance, Secures Continued Listing - TipRanks
Dyadic regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Dyadic International, Inc. (DYAI) stock price, news, quote and history - Yahoo Finance Singapore
Dyadic Announces Continued Listing on the Nasdaq Capital Market - GlobeNewswire
Dyadic International (NASDAQ:DYAI) Share Price Crosses Above 50-Day Moving AverageShould You Sell? - marketbeat.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program - GlobeNewswire
Analysts Expect Breakeven For Dyadic International, Inc. (NASDAQ:DYAI) Before Long - simplywall.st
Dyadic International stock reflects a thin catalyst day. Focus stays on its enzyme platform. - ad-hoc-news.de
DYAIDyadic International Inc, DE Forecast, Target Price - Finviz
Food Enzymes Market Size, Share, Analysis & Trends, 2034 - Market Data Forecast
Enzyme Complex Digestive Market Forecast 2026-2035: Growth Driven by Feed Efficiency and Antibiotic ReductionNews and Statistics - IndexBox
Dyadic Shareholders Approve Reverse Split and Governance Proposals - TipRanks
An Interview with the President & COO: How Dyadic is Commercializing Its Protein Platform Across Multi-Billion-Dollar Markets - TradingView
Dyadic Faces Nasdaq Delisting Review After Compliance Failures - TipRanks
World Enzyme-Based Waste DegradationMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Dyadic Showcases C1 Platform Amid Ebola Preparedness Surge - TipRanks
World Amyloglucosidase EnzymeMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
De-Inking Enzymes Market is Booming Worldwide | Major Giants Megazyme, BASF SE, DuPont - openPR.com
Enzyme Stabilizer Market Trends Support A 6.7% CAGR Outlook Through The Forecast Period - openPR.com
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: BioHarvest Sciences (BHST) and Brown Forman A (BF.A) - The Globe and Mail
Dyadic Under $1 as Investors Eye June Vote - Bez Kabli
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC) - The Globe and Mail
Dyadic International Launches Recombinant Human Albumin and Bovine Chymosin - asatunews.co.id
Analysts Offer Insights on Industrial Goods Companies: DroneShield Limited (OtherDRSHF), CryoPort (CYRX) and Deere (DE) - The Globe and Mail
Dyadic International (DYAI) Surges 13.8% – Key Levels in FocusETF AUM Growth - newsline.com
Dyadic and Scripps Research Partner to Accelerate Hantavirus Antibody and Vaccine Development Using C1 Biologic Platform - Minichart
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewswire Inc.
Skyline Corporate Communications Group, LLC Announces - GlobeNewswire
Dyadic International’s Earnings Call Shows Early Momentum - The Globe and Mail
Dyadic International Earnings Call Highlights Early Momentum - TipRanks
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss By Investing.com - Investing.com Australia
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss - Investing.com
Japan’s First LNG Shipment via Hormuz Since Strait’s De Facto Closure Marks Energy Security MilestoneAnalyst Coverage Count - The Legal Advocate
Dyadic International stock (US26746E1055): Shares climb after recent momentum - AD HOC NEWS
Dyadic International, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips - Investing.com India
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com India
Transcript: Dyadic International Q1 2026 Earnings Conference Call - Benzinga
Dyadic International (NASDAQ: DYAI) grows Q1 2026 revenue but flags going-concern risks - Stock Titan
Specialty Enzymes Market Overview, Emerging Trends, and Key Player Analysis - openPR.com
Analysis of Segments and Major Growth Areas in the Protein Hydrolysis Enzymes Market - openPR.com
Unusual VolumeStock ScreenerNews - Finviz
Biogen Inc. (BIIB)Dual Wall Street Upgrades Signal Bullish Pipeline Catalyst UpsideAnalyst Coverage Count - newsline.com
Dyadic International stock (US26746E1055): Is its biotech platform strong enough to unlock new upsid - AD HOC NEWS
New HighStock ScreenerSnapshot - Finviz
Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS
Top GainersStock ScreenerSnapshot - Finviz
Dyadic International Earnings Call Highlights Commercial Pivot - TipRanks
Dyadic International, Inc.'s (NASDAQ:DYAI) Path To Profitability - simplywall.st
Dyadic International Q4 2025 Earnings Call Transcript - MarketBeat
Dyadic Applied BioSolutions Reports 2025 Financial Results, Commercial Launches, and Strategic Partnerships in Animal-Free Protein Production 12346 - Minichart
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):